ASTH
Astrana Health, Inc.$38.09-1.51 (-3.81%)Prev Close$39.60·MCap$1.96B·P/E83.26·Vol167.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
6
$1.52M
◆
Net Activity
Net Seller
$1.52M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Astrana Health, Inc. (ASTH) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $1.52M. The most recent insider transaction was by Kumar Dinesh M. (Chief Medical Officer), who sold $292.2K worth of shares on Jan 23, 2026. Astrana Health, Inc. operates in the Healthcare sector, within the Medical - Care Facilities industry, with a market cap of $1.96B.
ASTH Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Kumar Dinesh M. | Chief Medical Officer | Sell | 10,759 | $27.16 | $292.2K | 0 |
| Jan 13, 2026 | Schmidt David | Director | Sell | 4,269 | $27.12 | $115.8K | 0 |
| Jan 1, 2026 | Kumar Dinesh M. | Chief Medical Officer | Sell | 5,102 | $24.81 | $126.6K | 0 |
| Dec 8, 2025 | Lam Thomas S. | Director | Sell | 25,866 | $22.00 | $569.1K | 0 |
| Nov 3, 2025 | Marsh Linda | Director | Sell | 11,033 | $32.99 | $364.0K | 0 |
| Oct 2, 2025 | Basho Chandan | COO and CFO | Sell | 1,979 | $27.77 | $55.0K | 0 |
| Sep 15, 2025 | Kitayama Mitchell W | Director | Sell | 13,214 | $30.23 | $399.5K | 0 |
| Sep 5, 2025 | Basho Chandan | COO and CFO | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 2, 2025 | Schmidt David | Director | Sell | 20,000 | $27.76 | $555.2K | 0 |
| Aug 13, 2025 | Chiang John | Director | Sell | 12,284 | $29.63 | $364.0K | 0 |
| Jul 1, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 6,831 | $25.06 | $171.2K | 0 |
| Jun 4, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,656 | $25.06 | $41.5K | 0 |
| May 16, 2025 | Basho Chandan | COO and CFO | Sell | 10,035 | $27.18 | $272.8K | 0 |
| Apr 29, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 828 | $31.15 | $25.8K | 0 |
| Apr 14, 2025 | Basho Chandan | COO and CFO | Sell | 2,683 | $34.05 | $91.4K | 0 |
| Apr 2, 2025 | Basho Chandan | COO and CFO | Sell | 1,394 | $30.02 | $41.8K | 0 |
| Mar 5, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,866 | $27.19 | $213.9K | 0 |
| Mar 5, 2025 | Lam Thomas S. | Director | Sell | 9,235 | $27.19 | $251.1K | 0 |
| Mar 5, 2025 | Sim Brandon | CEO and President | Sell | 105,795 | $27.19 | $2.88M | 0 |
| Jan 23, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,210 | $37.96 | $273.7K | 0 |
| Jan 1, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 967 | $31.53 | $30.5K | 0 |
| Dec 10, 2024 | Kitayama Mitchell W | Director | Sell | 5,100 | $43.09 | $219.8K | 0 |
| Nov 30, 2024 | Vong John | Chief Accounting Officer | Sell | 134 | $43.25 | $5.8K | 0 |
| Nov 22, 2024 | Kitayama Mitchell W | Director | Sell | 1,490 | $42.11 | $62.7K | 0 |
| Nov 19, 2024 | Chiang John | Director | Sell | 681 | $40.93 | $27.9K | 0 |
| Nov 12, 2024 | Vong John | Chief Accounting Officer | Sell | 636 | $42.91 | $27.3K | 0 |
| Nov 8, 2024 | Basho Chandan | COO and CFO | Sell | 691 | $46.96 | $32.4K | 0 |
| Oct 2, 2024 | Sim Brandon | CEO and President | Sell | 2,626 | $57.87 | $152.0K | 0 |
| Sep 10, 2024 | Marsh Linda | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 9, 2024 | Chiang John | Director | Sell | 3,565 | $47.35 | $168.8K | 0 |
| Sep 9, 2024 | Lam Thomas S. | Director | Sell | 11,046 | $47.35 | $523.0K | 0 |
| Aug 14, 2024 | Schmidt David | Director | Sell | 14,409 | $49.76 | $717.0K | 0 |
| Aug 1, 2024 | Kumar Dinesh M. | See remarks | Sell | 794 | $51.57 | $40.9K | 0 |
| Aug 1, 2024 | Vong John | Chief Accounting Officer | Sell | 67 | $51.57 | $3.5K | 0 |
| Jul 11, 2024 | Vong John | Chief Accounting Officer | Sell | 336 | $45.00 | $15.1K | 0 |
| May 16, 2024 | Basho Chandan | COO and CFO | Sell | 7,051 | $41.13 | $290.0K | 0 |
| May 12, 2024 | Vong John | Chief Accounting Officer | Sell | 636 | $38.89 | $24.7K | 0 |
| Mar 29, 2024 | Basho Chandan | COO and CFO | Sell | 14,500 | $41.29 | $598.7K | 0 |
| Mar 29, 2024 | Sim Brandon | CEO and President | Sell | 37,957 | $41.99 | $1.59M | 0 |
| Dec 6, 2023 | Schmidt David | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Nov 30, 2023 | Vong John | Chief Accounting Officer | Sell | 65 | $33.23 | $2.2K | 0 |
| May 16, 2023 | Vong John | Chief Accounting Officer | Sell | 325 | $32.07 | $10.4K | 0 |
| Apr 14, 2023 | Basho Chandan | See Remarks | Sell | 2,494 | $39.06 | $97.4K | 0 |
| Mar 14, 2023 | Marsh Linda | Director | Sell | 270,081 | $35.32 | $9.54M0.5% OS | 0 |
| Jun 17, 2022 | Marsh Linda | Director | Sell | 250,000 | $37.00 | $9.25M | 0 |
| Mar 31, 2022 | Chin Eric | Chief Financial Officer | Sell | 469 | $48.47 | $22.7K | 0 |
| Mar 31, 2022 | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $48.47 | $12.4K | 0 |
| Feb 3, 2022 | Chin Eric | Chief Financial Officer | Sell | 2,802 | $50.71 | $142.1K | 0 |
| Aug 17, 2021 | Schmidt David | Director | Sell | 40,000 | $73.67 | $2.95M | 0 |
| Jun 15, 2021 | Young Albert WaiChow | Chief Administrative Officer | Sell | 5,000 | $48.58 | $242.9K | 0 |
Showing 1–50 of 55
1 / 2
ASTH Insider Buying Activity
The following table shows recent insider purchases of Astrana Health, Inc. (ASTH) stock reported via SEC Form 4 filings.
No insider buying activity found for ASTH in the last 12 months.
ASTH Insider Selling Activity
The following table shows recent insider sales of Astrana Health, Inc. (ASTH) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Kumar Dinesh M. | Chief Medical Officer | Sell | 10,759 | $27.16 | $292.2K | 0 |
| Jan 13, 2026 | Schmidt David | Director | Sell | 4,269 | $27.12 | $115.8K | 0 |
| Jan 1, 2026 | Kumar Dinesh M. | Chief Medical Officer | Sell | 5,102 | $24.81 | $126.6K | 0 |
| Dec 8, 2025 | Lam Thomas S. | Director | Sell | 25,866 | $22.00 | $569.1K | 0 |
| Nov 3, 2025 | Marsh Linda | Director | Sell | 11,033 | $32.99 | $364.0K | 0 |
| Oct 2, 2025 | Basho Chandan | COO and CFO | Sell | 1,979 | $27.77 | $55.0K | 0 |
| Sep 15, 2025 | Kitayama Mitchell W | Director | Sell | 13,214 | $30.23 | $399.5K | 0 |
| Sep 5, 2025 | Basho Chandan | COO and CFO | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 2, 2025 | Schmidt David | Director | Sell | 20,000 | $27.76 | $555.2K | 0 |
| Aug 13, 2025 | Chiang John | Director | Sell | 12,284 | $29.63 | $364.0K | 0 |
| Jul 1, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 6,831 | $25.06 | $171.2K | 0 |
| Jun 4, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,656 | $25.06 | $41.5K | 0 |
| May 16, 2025 | Basho Chandan | COO and CFO | Sell | 10,035 | $27.18 | $272.8K | 0 |
| Apr 29, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 828 | $31.15 | $25.8K | 0 |
| Apr 14, 2025 | Basho Chandan | COO and CFO | Sell | 2,683 | $34.05 | $91.4K | 0 |
| Apr 2, 2025 | Basho Chandan | COO and CFO | Sell | 1,394 | $30.02 | $41.8K | 0 |
| Mar 5, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,866 | $27.19 | $213.9K | 0 |
| Mar 5, 2025 | Lam Thomas S. | Director | Sell | 9,235 | $27.19 | $251.1K | 0 |
| Mar 5, 2025 | Sim Brandon | CEO and President | Sell | 105,795 | $27.19 | $2.88M | 0 |
| Jan 23, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,210 | $37.96 | $273.7K | 0 |
| Jan 1, 2025 | Kumar Dinesh M. | Chief Medical Officer | Sell | 967 | $31.53 | $30.5K | 0 |
| Dec 10, 2024 | Kitayama Mitchell W | Director | Sell | 5,100 | $43.09 | $219.8K | 0 |
| Nov 30, 2024 | Vong John | Chief Accounting Officer | Sell | 134 | $43.25 | $5.8K | 0 |
| Nov 22, 2024 | Kitayama Mitchell W | Director | Sell | 1,490 | $42.11 | $62.7K | 0 |
| Nov 19, 2024 | Chiang John | Director | Sell | 681 | $40.93 | $27.9K | 0 |
| Nov 12, 2024 | Vong John | Chief Accounting Officer | Sell | 636 | $42.91 | $27.3K | 0 |
| Nov 8, 2024 | Basho Chandan | COO and CFO | Sell | 691 | $46.96 | $32.4K | 0 |
| Oct 2, 2024 | Sim Brandon | CEO and President | Sell | 2,626 | $57.87 | $152.0K | 0 |
| Sep 10, 2024 | Marsh Linda | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 9, 2024 | Chiang John | Director | Sell | 3,565 | $47.35 | $168.8K | 0 |
| Sep 9, 2024 | Lam Thomas S. | Director | Sell | 11,046 | $47.35 | $523.0K | 0 |
| Aug 14, 2024 | Schmidt David | Director | Sell | 14,409 | $49.76 | $717.0K | 0 |
| Aug 1, 2024 | Kumar Dinesh M. | See remarks | Sell | 794 | $51.57 | $40.9K | 0 |
| Aug 1, 2024 | Vong John | Chief Accounting Officer | Sell | 67 | $51.57 | $3.5K | 0 |
| Jul 11, 2024 | Vong John | Chief Accounting Officer | Sell | 336 | $45.00 | $15.1K | 0 |
| May 16, 2024 | Basho Chandan | COO and CFO | Sell | 7,051 | $41.13 | $290.0K | 0 |
| May 12, 2024 | Vong John | Chief Accounting Officer | Sell | 636 | $38.89 | $24.7K | 0 |
| Mar 29, 2024 | Basho Chandan | COO and CFO | Sell | 14,500 | $41.29 | $598.7K | 0 |
| Mar 29, 2024 | Sim Brandon | CEO and President | Sell | 37,957 | $41.99 | $1.59M | 0 |
| Dec 6, 2023 | Schmidt David | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Nov 30, 2023 | Vong John | Chief Accounting Officer | Sell | 65 | $33.23 | $2.2K | 0 |
| May 16, 2023 | Vong John | Chief Accounting Officer | Sell | 325 | $32.07 | $10.4K | 0 |
| Apr 14, 2023 | Basho Chandan | See Remarks | Sell | 2,494 | $39.06 | $97.4K | 0 |
| Mar 14, 2023 | Marsh Linda | Director | Sell | 270,081 | $35.32 | $9.54M0.5% OS | 0 |
| Jun 17, 2022 | Marsh Linda | Director | Sell | 250,000 | $37.00 | $9.25M | 0 |
| Mar 31, 2022 | Chin Eric | Chief Financial Officer | Sell | 469 | $48.47 | $22.7K | 0 |
| Mar 31, 2022 | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $48.47 | $12.4K | 0 |
| Feb 3, 2022 | Chin Eric | Chief Financial Officer | Sell | 2,802 | $50.71 | $142.1K | 0 |
| Aug 17, 2021 | Schmidt David | Director | Sell | 40,000 | $73.67 | $2.95M | 0 |
| Jun 15, 2021 | Young Albert WaiChow | Chief Administrative Officer | Sell | 5,000 | $48.58 | $242.9K | 0 |
ASTH Insiders
Similar Stocks to ASTH
THC
Tenet Healthcare Corporation
$260.33-1.62%
$21.23B
EHC
Encompass Health Corporation
$121.62-0.76%
$12.07B
DVA
DaVita Inc.
$190.79+0.78%
$11.66B
ENSG
The Ensign Group, Inc.
$173.87-0.54%
$10.14B
PACS
PACS Group, Inc.
$41.89-5.98%
$7.09B
HIMS
Hims & Hers Health, Inc.
$28.11-2.45%
$6.14B
LFST
LifeStance Health Group, Inc.
$13.04-2.54%
$5.03B
CON
Concentra Group Holdings Parent, Inc.
$35.67-0.39%
$4.47B